Results

Total Results: 450 records

Showing results for "regions".

41. Roadmap Phase 3 - Scaling 5E03A2F9F11A47299F21D00C366508Ff-020823-0154-2068 (pdf file)
    cmext.ahrq.gov/confluence/download/export/pdfexport-20230802-020823-0154-2067/Roadmap+Phase+3+-+Scaling_5e03a2f9f11a47299f21d00c366508ff-020823-0154-2068.pdf?contentType=application/pdf
    and 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

42. Roadmap Phase 3 - Scaling C5Ad913Be4F8416398Ad4Ecaccdae5Dc-020823-0155-2070 (pdf file)
    cmext.ahrq.gov/confluence/download/export/pdfexport-20230802-020823-0155-2069/Roadmap+Phase+3+-+Scaling_c5ad913be4f8416398ad4ecaccdae5dc-020823-0155-2070.pdf?contentType=application/pdf
    and 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

43. Roadmap Phase 3 - Scaling 31A79632A0674C9Fa00F181616Db5Ba6-310723-2036-472 (pdf file)
    cmext.ahrq.gov/confluence/download/export/pdfexport-20230731-310723-2036-471/Roadmap+Phase+3+-+Scaling_31a79632a0674c9fa00f181616db5ba6-310723-2036-472.pdf?contentType=application/pdf
    and 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

44. Acknowledgements
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991588&selectedPageVersions=10&selectedPageVersions=9
    October 07, 2021 - Skip to main content assistive.skiplink.to.breadcrumbs assistive.skiplink.to.header.menu assistive.skiplink.to.action.menu assistive.skiplink.to.quick.search Required: page refresh 5 An official website of the Department of Health & Human Services      …

45. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114991753&pageId=114991746
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

46. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114992852&pageId=114991079
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

47. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991079
    August 04, 2022 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

48. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114992852
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

49. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991746
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

50. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114991753
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

51. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114991746&pageId=114992852
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

52. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=1&pageId=114991079&revisedVersion=4
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

53. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=3&pageId=114991079&revisedVersion=4
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

54. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114992852&selectedPageVersions=2&selectedPageVersions=3
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

55. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991746&selectedPageVersions=1&selectedPageVersions=2
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

56. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114992852
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

57. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991753
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

58. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114991746
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

59. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=2&pageId=114991079&revisedVersion=4
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions

60. Roadmap Phase 3 - Scaling
    cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114991079&selectedPageVersions=3&selectedPageVersions=4
    September 20, 2021 - 2 clinical targets in at least 50 different CDOs (with wide variation in size, populations and regions